Congestive heart failure: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
{{Congestive heart failure}} | {{Congestive heart failure}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}; Atif Mohammad, | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}; Atif Mohammad, M.D. | ||
'''''Synonyms and Related Key Words:''''' CHF, pump failure, left heart failure, right heart failure, chronic heart failure, acute heart failure, flash pulmonary edema, congestion, systolic dysfunction, LV dysfunction, LV failure, impaired filling, reduced cardiac output, pulmonary edema | '''''Synonyms and Related Key Words:''''' CHF, pump failure, left heart failure, right heart failure, chronic heart failure, acute heart failure, flash pulmonary edema, congestion, systolic dysfunction, LV dysfunction, LV failure, impaired filling, reduced cardiac output, pulmonary edema | ||
| Line 38: | Line 38: | ||
[[Congestive heart failure clinical assessment|Clinical Assessment]] | [[Congestive heart failure history and symptoms|History & Symptoms]] | [[Congestive heart failure physical examination|Physical Examination]] | [[Congestive heart failure laboratory tests|Lab Tests]] | [[Congestive heart failure electrocardiogram|Electrocardiogram]] | [[Congestive heart failure chest x ray|Chest X Ray]] | [[Congestive heart failure echocardiography|Echocardiography]] | [[Congestive heart failure imaging modalities|Imaging Modalities]] | [[Congestive heart failure other diagnostic studies|Other Diagnostic Studies]] | [[Congestive heart failure clinical assessment|Clinical Assessment]] | [[Congestive heart failure history and symptoms|History & Symptoms]] | [[Congestive heart failure physical examination|Physical Examination]] | [[Congestive heart failure laboratory tests|Lab Tests]] | [[Congestive heart failure electrocardiogram|Electrocardiogram]] | [[Congestive heart failure chest x ray|Chest X Ray]] | [[Congestive heart failure echocardiography|Echocardiography]] | [[Congestive heart failure imaging modalities|Imaging Modalities]] | [[Congestive heart failure other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==[[Congestive heart failure overview of treatment|Treatment]]== | ||
====Medical Therapy:==== | |||
: '''[[Congestive heart failure overview of treatment#Acute Pharmacotherapy|Acute Pharmacotherapy]]''' | |||
: '''[[Congestive heart failure overview of treatment#Chronic Pharmacotherapy|Chronic Pharmacotherapy]]:''' [[Congestive heart failure overview of treatment#Diuretics|Diuretics]] | [[Congestive heart failure overview of treatment#Renin-Angiotensin-Aldosterone Axis Inhibitors|Renin-Angiotensin-Aldosterone Axis Inhibitors]] | [[Congestive heart failure overview of treatment#Nitrates|Nitrates]] | [[Congestive heart failure overview of treatment#Anticoagulants|Anticoagulants]] | [[Congestive heart failure overview of treatment#Beta Blockers|Beta Blockers]] | [[Congestive heart failure overview of treatment#Antiarrhythmic Drugs|Antiarrhythmic Drugs]] | [[Congestive heart failure overview of treatment#Positive Inotropics|Positive Inotropics]] | [[Congestive heart failure overview of treatment#Metformin|Metformin]] | [[Congestive heart failure overview of treatment#Ca Channel Blockers|Ca Channel Blockers]] | |||
====[[Congestive heart failure overview of treatment| | ====Surgical Therapy:==== | ||
[[Congestive heart failure overview of treatment#Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)|Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)]] | [[Congestive heart failure overview of treatment#Implantation of Intracardiac Defibrillator|Implantation of Intracardiac Defibrillator]] | [[Congestive heart failure overview of treatment#Ultrafiltration|Ultrafiltration]] | [[Congestive heart failure overview of treatment#Left Ventricular Assist Devices (LVADs)|Left Ventricular Assist Devices (LVADs)]] | [[Congestive heart failure overview of treatment#Cardiac Transplantation|Cardiac Transplantation]] | [[Congestive heart failure overview of treatment#Invasive Monitoring|Invasive Monitoring]] | |||
====[[Congestive heart failure AHA recommendations for hospitalized patient| | ==Guideline Recommendations== | ||
=====[[Congestive heart failure AHA recommendations for hospitalized patient|Hospitalized Patients]]===== | |||
====[[Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)| | =====[[Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)|Patients at high risk for developing heart failure (Stage A)]]===== | ||
====[[Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)| | =====[[Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)|Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)]]===== | ||
====[[Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)| | =====[[Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)|Patients with current or prior symptoms of heart failure (Stage C)]]===== | ||
====[[Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)| | =====[[Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)|Patients with refractory end-stage heart failure (Stage D)]]===== | ||
==[[Congestive heart failure implementation of practice guidelines|Implementation of Practice Guidelines]]== | |||
==[[Congestive heart failure end-of-life considerations|End-Of-Life Considerations]]== | ==[[Congestive heart failure end-of-life considerations|End-Of-Life Considerations]]== | ||
==[[Congestive heart failure | ==Specific Groups== | ||
[[Congestive heart failure treatment of special populations|Special Populations]] | [[Congestive heart failure treatment of patients who have concomitant disorders|Patients who have concomitant disorders]] | [[Congestive heart failure overview of treatment#Obstructive Sleep Apnea in the Patient with CHF|Obstructive Sleep Apnea in the Patient with CHF]] | |||
==Guidelines Resources== | ==Guidelines Resources== | ||
Revision as of 16:45, 2 November 2011
For patient information click here
| Heart failure | |
| ICD-10 | I50.0 |
|---|---|
| ICD-9 | 428.0 |
| DiseasesDB | 16209 |
| MedlinePlus | 000158 |
| MeSH | D006333 |
| Congestive Heart Failure Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Congestive heart failure from other Diseases |
|
Diagnosis |
|
Treatment |
|
Medical Therapy: |
|
Surgical Therapy: |
|
ACC/AHA Guideline Recommendations
|
|
Specific Groups: |
|
Congestive heart failure On the Web |
|
Risk calculators and risk factors for Congestive heart failure |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Atif Mohammad, M.D.
Synonyms and Related Key Words: CHF, pump failure, left heart failure, right heart failure, chronic heart failure, acute heart failure, flash pulmonary edema, congestion, systolic dysfunction, LV dysfunction, LV failure, impaired filling, reduced cardiac output, pulmonary edema
Overview
Classification
Pathophysiology
Epidemiology and Demographics
Natural history, complications & prognosis
Causes
Risk Factors
Differential Diagnosis
Diagnosis
Clinical Assessment | History & Symptoms | Physical Examination | Lab Tests | Electrocardiogram | Chest X Ray | Echocardiography | Imaging Modalities | Other Diagnostic Studies
Treatment
Medical Therapy:
- Acute Pharmacotherapy
- Chronic Pharmacotherapy: Diuretics | Renin-Angiotensin-Aldosterone Axis Inhibitors | Nitrates | Anticoagulants | Beta Blockers | Antiarrhythmic Drugs | Positive Inotropics | Metformin | Ca Channel Blockers
Surgical Therapy:
Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) | Implantation of Intracardiac Defibrillator | Ultrafiltration | Left Ventricular Assist Devices (LVADs) | Cardiac Transplantation | Invasive Monitoring
Guideline Recommendations
Hospitalized Patients
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)
Implementation of Practice Guidelines
End-Of-Life Considerations
Specific Groups
Special Populations | Patients who have concomitant disorders | Obstructive Sleep Apnea in the Patient with CHF
Guidelines Resources
- The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult [1]
- 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation [2]
References
- ↑ Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (12):e154-235. DOI:10.1161/CIRCULATIONAHA.105.167586 PMID: 16160202
- ↑ Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14):1977-2016. DOI:10.1161/CIRCULATIONAHA.109.192064 PMID: 19324967